A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

  First | 1 2 3        [Sort by number of followers]   [Restore default list]

  Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
Showing 401 - 253 of 253 Journals sorted alphabetically
Microbial Drug Resistance     Hybrid Journal   (Followers: 3)
Molecular Informatics     Hybrid Journal   (Followers: 5)
Molecular Pharmacology     Hybrid Journal   (Followers: 2)
Molekul     Open Access   (Followers: 1)
Natural Product Communications     Open Access  
Nature Reviews Drug Discovery     Full-text available via subscription   (Followers: 310)
Naunyn-Schmiedeberg's Archives of Pharmacology     Hybrid Journal  
NeuroMolecular Medicine     Hybrid Journal  
Neuropharmacology     Hybrid Journal   (Followers: 5)
Neuropsychopharmacology     Hybrid Journal   (Followers: 17)
Neuropsychopharmacology Reports     Open Access  
Nigerian Journal of Natural Products and Medicine     Full-text available via subscription  
OA Drug Design & Delivery     Open Access  
OA Medical Hypothesis     Open Access  
Obesity Facts     Open Access   (Followers: 8)
Open Pharmacoeconomics & Health Economics Journal     Open Access   (Followers: 1)
Open Pharmacology Journal     Open Access  
OpenNano     Open Access   (Followers: 1)
Orbital - The Electronic Journal of Chemistry     Open Access   (Followers: 1)
Oriental Pharmacy and Experimental Medicine     Partially Free   (Followers: 2)
Pain and Therapy     Open Access   (Followers: 3)
Particulate Science and Technology: An International Journal     Hybrid Journal   (Followers: 1)
PDA Journal of Pharmaceutical Science and Technology     Full-text available via subscription   (Followers: 33)
Pediatric Drugs     Full-text available via subscription   (Followers: 3)
Pediatric Pharmacology     Open Access   (Followers: 1)
Pharmaceutica Analytica Acta     Open Access  
Pharmaceutical Biology     Open Access  
Pharmaceutical Care-La Farmacoterapia     Open Access  
Pharmaceutical Chemistry Journal     Hybrid Journal  
Pharmaceutical Development and Technology     Hybrid Journal   (Followers: 19)
Pharmaceutical Executive     Full-text available via subscription   (Followers: 2)
Pharmaceutical Fronts     Open Access   (Followers: 8)
Pharmaceutical Historian     Open Access  
Pharmaceutical Journal     Free   (Followers: 8)
Pharmaceutical Journal of Sri Lanka     Open Access  
Pharmaceutical Medicine     Full-text available via subscription   (Followers: 4)
Pharmaceutical Nanotechnology     Hybrid Journal  
Pharmaceutical Patent Analyst     Full-text available via subscription   (Followers: 3)
Pharmaceutical Research     Hybrid Journal   (Followers: 93)
Pharmaceutical Statistics     Hybrid Journal   (Followers: 15)
Pharmaceutical Technology     Full-text available via subscription   (Followers: 6)
Pharmaceuticals     Open Access   (Followers: 4)
Pharmacia     Open Access  
Pharmaciana     Open Access  
PharmacoEconomics     Full-text available via subscription   (Followers: 25)
PharmacoEconomics & Outcomes News     Full-text available via subscription   (Followers: 2)
PharmacoEconomics German Research Articles     Full-text available via subscription  
PharmacoEconomics Spanish Research Articles     Hybrid Journal   (Followers: 1)
Pharmacoepidemiology and Drug Safety     Hybrid Journal   (Followers: 33)
Pharmacogenetics and Genomics     Hybrid Journal   (Followers: 1)
Pharmacogenomics     Hybrid Journal   (Followers: 7)
Pharmacogenomics and Personalized Medicine     Open Access   (Followers: 2)
Pharmacogenomics Journal     Hybrid Journal   (Followers: 5)
Pharmacognosy Communications     Partially Free  
Pharmacognosy Magazine     Open Access   (Followers: 2)
Pharmacognosy Research     Open Access   (Followers: 2)
Pharmacological Reports     Hybrid Journal  
Pharmacological Research     Hybrid Journal   (Followers: 1)
Pharmacological Research - Modern Chinese Medicine     Open Access  
Pharmacological Reviews     Hybrid Journal   (Followers: 2)
Pharmacology     Full-text available via subscription  
Pharmacology & Therapeutics     Hybrid Journal   (Followers: 3)
Pharmacology & Pharmacy     Open Access   (Followers: 1)
Pharmacology Biochemistry and Behavior     Hybrid Journal   (Followers: 2)
Pharmacology Research & Perspectives     Open Access  
Pharmacon : Jurnal Farmasi Indonesia     Open Access  
Pharmacopsychiatry     Hybrid Journal   (Followers: 3)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy     Hybrid Journal   (Followers: 37)
Pharmactuel     Open Access   (Followers: 1)
Pharmacy     Open Access   (Followers: 4)
Pharmacy & Pharmacology     Open Access   (Followers: 1)
Pharmacy Education     Full-text available via subscription   (Followers: 11)
Pharmacy Practice (Internet)     Open Access   (Followers: 8)
Pharmakon : Arzneimittel in Wissenschaft und Praxis     Full-text available via subscription   (Followers: 1)
PharmaNutrition     Hybrid Journal   (Followers: 3)
PharmaTutor     Open Access  
Pharmazeutische Industrie     Full-text available via subscription   (Followers: 9)
Pharmazeutische Zeitung     Full-text available via subscription   (Followers: 11)
Pharmazie in Unserer Zeit (Pharmuz)     Hybrid Journal   (Followers: 11)
Physiology International     Full-text available via subscription   (Followers: 3)
Plant Products Research Journal     Full-text available via subscription  
Planta Medica     Hybrid Journal   (Followers: 4)
Planta Medica International Open     Open Access  
Prescriber     Hybrid Journal   (Followers: 9)
Progress in Neuro-Psychopharmacology and Biological Psychiatry     Hybrid Journal   (Followers: 8)
Psychiatry and Clinical Psychopharmacology     Open Access   (Followers: 1)
Psychopharmacology     Hybrid Journal   (Followers: 15)
Pulmonary Pharmacology & Therapeutics     Hybrid Journal   (Followers: 2)
PZ Prisma : Materialien zur Fort- und Weiterbildung     Full-text available via subscription  
Redox Report     Open Access  
Regulatory Mechanisms in Biosystems     Open Access   (Followers: 1)
Regulatory Toxicology and Pharmacology     Hybrid Journal   (Followers: 41)
Research & Reviews : A Journal of Drug Design & Discovery     Full-text available via subscription  
Research & Reviews : A Journal of Pharmaceutical Science     Full-text available via subscription  
Research & Reviews : A Journal of Pharmacognosy     Full-text available via subscription  
Research & Reviews : A Journal of Pharmacology     Full-text available via subscription   (Followers: 1)
Research in Pharmaceutical Sciences     Open Access   (Followers: 3)
Research in Social and Administrative Pharmacy     Hybrid Journal   (Followers: 3)
Research Journal of Pharmacognosy     Open Access  
Research Results in Pharmacology     Open Access  
Reviews of Physiology, Biochemistry and Pharmacology     Hybrid Journal   (Followers: 4)
Reviews on Clinical Pharmacology and Drug Therapy     Full-text available via subscription  
Revista Colombiana de Ciencias Químico-Farmacéuticas     Open Access  
Revista Cubana de Plantas Medicinales     Open Access   (Followers: 1)
Revista de Ciências Farmacêuticas Básica e Aplicada     Open Access  
Revista Mexicana de Ciencias Farmaceuticas     Open Access  
Revue de Médecine et de Pharmacie     Full-text available via subscription  
Safety and Risk of Pharmacotherapy     Open Access   (Followers: 1)
Saudi Pharmaceutical Journal     Open Access  
Scandinavian Journal of Clinical and Laboratory Investigation     Hybrid Journal   (Followers: 7)
Scientia Pharmaceutica     Open Access  
Seminars in Hematology     Hybrid Journal   (Followers: 12)
Seminars in Oncology Nursing     Full-text available via subscription   (Followers: 10)
Separation Science plus (SSC plus)     Hybrid Journal  
Side Effects of Drugs Annual     Full-text available via subscription   (Followers: 2)
Skin Pharmacology and Physiology     Full-text available via subscription   (Followers: 6)
Substance Abuse : Research and Treatment     Open Access   (Followers: 5)
Suchttherapie     Hybrid Journal   (Followers: 1)
Sustainable Chemistry and Pharmacy     Full-text available via subscription   (Followers: 1)
Synfacts     Hybrid Journal   (Followers: 5)
SynOpen     Open Access  
The Botulinum J.     Hybrid Journal  
The Brown University Psychopharmacology Update     Hybrid Journal   (Followers: 2)
The Medical Letter     Full-text available via subscription   (Followers: 18)
The Pink Sheet     Full-text available via subscription   (Followers: 12)
The Pink Sheet Daily     Full-text available via subscription   (Followers: 4)
Therapeutic Advances in Drug Safety     Open Access   (Followers: 3)
Therapeutic Advances in Psychopharmacology     Open Access   (Followers: 4)
Therapeutic Advances in Vaccines     Hybrid Journal   (Followers: 1)
Therapeutic Drug Monitoring     Hybrid Journal   (Followers: 3)
Therapeutic Innovation & Regulatory Science     Hybrid Journal   (Followers: 7)
Thérapie     Full-text available via subscription   (Followers: 1)
TheScientist     Free   (Followers: 5)
Toxicological & Environmental Chemistry     Hybrid Journal   (Followers: 2)
Toxicological Research     Hybrid Journal  
Toxicological Sciences     Hybrid Journal   (Followers: 11)
Toxicology     Hybrid Journal   (Followers: 18)
Toxicology and Applied Pharmacology     Hybrid Journal   (Followers: 24)
Toxicology and Industrial Health     Hybrid Journal   (Followers: 6)
Toxicology in Vitro     Hybrid Journal   (Followers: 11)
Toxicology International     Full-text available via subscription   (Followers: 5)
Toxicology Letters     Hybrid Journal   (Followers: 15)
Toxicology Mechanisms and Methods     Hybrid Journal   (Followers: 7)
Toxicology Research     Partially Free   (Followers: 8)
Toxicon     Hybrid Journal   (Followers: 5)
Toxicon : X     Open Access  
Toxin Reviews     Hybrid Journal  
Translational Psychiatry     Open Access   (Followers: 14)
Trends in Peptide and Protein Sciences     Open Access  
Trends in Pharmacological Sciences     Full-text available via subscription   (Followers: 19)
Tropical Journal of Pharmaceutical Research     Open Access  
Ukrainian Biopharmaceutical Journal     Open Access  
Vascular Pharmacology     Hybrid Journal   (Followers: 2)
World Mycotoxin Journal     Hybrid Journal   (Followers: 3)
Yakugaku Zasshi     Open Access   (Followers: 1)
Zeitschrift für Phytotherapie     Hybrid Journal   (Followers: 1)
Актуальні питання фармацевтичної та медичної науки та практики     Open Access  
Фармацевтичний часопис     Open Access  

  First | 1 2 3        [Sort by number of followers]   [Restore default list]

Similar Journals
Journal Cover
Indian Journal of Drugs in Dermatology
Journal Prestige (SJR): 0.791
Citation Impact (citeScore): 1
Number of Followers: 1  

  This is an Open Access Journal Open Access journal
ISSN (Print) 2455-3972
Published by Medknow Publishers Homepage  [448 journals]
  • Oral minoxidil in trichology: A review

    • Authors: Priyanka Arun Kowe, Bhushan Madke, Shashank Hemant Bansod
      Pages: 1 - 6
      Abstract: Priyanka Arun Kowe, Bhushan Madke, Shashank Hemant Bansod
      Indian Journal of Drugs in Dermatology 2022 8(1):1-6
      Minoxidil, a pro-drug has been used as an oral antihypertensive drug since the 1960s. Though it was initially introduced as a therapy to control hypertension, it became popular after its coincidental finding on the promotion of hair growth and stimulation of new hair production. This has led to the usefulness of minoxidil in treating several hair loss disorders in both topical and oral forms. In 1988, Food and drug administration (FDA) approved topical minoxidil (TM) 2% for the treatment of male androgenetic alopecia (AGA) and in 1992, it got approval for female pattern hair loss (FPHL). Since then the use of TM has increased tremendously. However, there are frequent reports of TM and/or its vehicle-induced contact dermatitis which has reduced the compliance in the patients resulted in a poor outcome. Oral minoxidil (OM) has been tried and found useful in AGA, alopecia areata (AA), traction alopecia (TA), chronic telogen effluvium (CTE), chemotherapy-induced alopecia, monilethrix, and several other alopecia’s; however, the exact mechanism of action and efficacy of oral minoxidil in these disorders remains undetermined. Also, when given in low dose, side effect profile of OM has been found comparable to that of TM. The above data was supported by case series, randomized control trials, and case reports with a low quality of evidence. In this review, we aimed to summarize the different indications of oral minoxidil. We reiterate the claim that high-quality studies are needed before advocating use of oral minoxidil in hair disorders.
      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):1-6
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_35_21
      Issue No: Vol. 8, No. 1 (2022)
       
  • Serum and sebum pharmacokinetics evaluation of a novel formulation of
           itraconazole in healthy volunteers

    • Authors: Harshal Mahajan, Gaurav K Jain, Dhiraj Dhoot, Gaurav A Deshmukh, Hanmant V Barkate
      Pages: 7 - 14
      Abstract: Harshal Mahajan, Gaurav K Jain, Dhiraj Dhoot, Gaurav A Deshmukh, Hanmant V Barkate
      Indian Journal of Drugs in Dermatology 2022 8(1):7-14
      Background and Objective: Super bioavailable itraconazole is a newer formulation of itraconazole, which overcomes challenges encountered with the use of conventional itraconazole like interpatient variability, limited absorption, reduction in its absorption with co-administered gastric acid lowering agents, etc. The present study was done to evaluate the plasma pharmacokinetics, sebum concentrations of super bioavailable itraconazole in comparison with conventional itraconazole. Materials and Methods: Twelve healthy Asian Indian male healthy volunteers were enrolled in single-center, open-labeled, two treatments, multi-dose, parallel pharmacokinetic study. Test drug (T), i.e. super bioavailable itraconazole 50 mg, was given to six volunteers twice daily after meals for 7 continuous days. Reference drug (R), i.e. conventional itraconazole 100 mg, was given in similar way to the remaining six volunteers. Concentration of the itraconazole in plasma in both the groups was quantified by using high performance liquid chromatography. Concentration of the itraconazole in sebum was measured by paper absorption method. Results: The plasma concentration of itraconazole in both the groups was comparable at all-time points. The maximum concentration (Cmax) and area under curve in test group was higher as compared to reference group. The relative bioavailability of test drug was 107% as compared to the reference drug. The intersubject variability was less in test group (8.37%) as compared to reference drug (19.82%). At day 7, the mean sebum concentration of itraconazole in test drug group was 11.6% higher as compared to reference drug (P = 0.01). Conclusion: It is apparent from the study outcomes that super bioavailable itraconazole (50 mg) is bioequivalent to the conventional itraconazole (100 mg) along with less intersubject variability, and most importantly higher sebum concentration as compared to conventional itraconazole.
      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):7-14
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_23_21
      Issue No: Vol. 8, No. 1 (2022)
       
  • Dermatological adverse events of cancer chemotherapy: An observational
           clinicoepidemiological study from a tertiary care center

    • Authors: Guneet Awal, Guramrit Singh
      Pages: 15 - 22
      Abstract: Guneet Awal, Guramrit Singh
      Indian Journal of Drugs in Dermatology 2022 8(1):15-22
      Introduction: Although newer chemotherapeutic drugs prolong patients’ survival, they cause a myriad of dermatological adverse effects leading to decreased quality of life. Aims and Objectives: The study was undertaken to assess the various cutaneous adverse effects associated with chemotherapeutic drugs. Materials and Methods: A total of 736 diagnosed cancer patients on chemotherapy attending the dermatology department of a tertiary care center were studied in this observational study between June 2019 and May 2021. Detailed dermatological examination to include skin, hair, nail, and mucosal changes was undertaken after informed consent. Results: The most common malignancy observed was breast carcinoma, which was seen in 21.33% of the cases. It was followed by carcinoma cervix in 12.09% of the cases. Most commonly implicated drugs were platinum therapy (cisplatin, carboplatin) and anthracyclines (doxorubicin and epirubicin). Alopecia was the most common adverse effect seen in 55.84% of the patients. It was followed by hand-foot syndrome in 11% of the patients. Nail changes were seen in 4.21% of the patients, and the most common nail finding was longitudinal melanonychia seen in 1.49% of the patients. Conclusion: Knowledge regarding occurrence and severity of dermatological side effects of chemotherapy aids in early recognition and treatment. It also benefits in educating patients regarding potential adverse effects, taking appropriate prophylactic measures, and therefore better compliance by the patient.
      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):15-22
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_36_21
      Issue No: Vol. 8, No. 1 (2022)
       
  • A case series of generalized Lichenoid Drug Eruption due to
           Anti-Tubercular Drugs: Treated with immunosuppressant’s while
           continuing Anti-Tubercular therapy

    • Authors: Hari Pathave, Atul Dongre, Gayatri Gund, Sapna Goutham, Chitra Nayak
      Pages: 23 - 28
      Abstract: Hari Pathave, Atul Dongre, Gayatri Gund, Sapna Goutham, Chitra Nayak
      Indian Journal of Drugs in Dermatology 2022 8(1):23-28
      The spectrum of tuberculosis-associated cutaneous adverse drug reactions (ADRs) is wide and includes Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and generalized lichenoid drug eruption (LDE). LDE constitutes less than 10% of the total incidence of anti-tubercular drug induced cutaneous ADRs. In any type of drug reaction there is a prompt need of withdrawal of suspected drugs and institution of aggressive treatment of ADRs with proper control of underlying primary disease. Herein, we present a case series of five cases of generalized LDE due to anti tubercular therapy (ATT), in whom cutaneous lesions were managed with oral immunosuppressants while continuing ATT.
      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):23-28
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_65_20
      Issue No: Vol. 8, No. 1 (2022)
       
  • Topical 5-fluorouracil for Basal Cell Carcinoma

    • Authors: Anil Balkrishna Bhokare
      Pages: 29 - 31
      Abstract: Anil Balkrishna Bhokare
      Indian Journal of Drugs in Dermatology 2022 8(1):29-31
      Basal cell carcinoma is a malignant epithelial tumor arising only in skin, from the basal layer of the epidermis or of the pilosebaceous adnexa. Diagnosis often depends on skin examination, confirmed by tissue biopsy. Treatment is typically by surgical removal. This can be by simple excision if the cancer is small; otherwise Mohs surgery is generally recommended. Other options may include topical chemotherapy, laser therapy, or the use of imiquimod. In this study, we conclude topical 5-fluorouracil is a highly effective and well-tolerated treatment option for superficial basal cell carcinomas.
      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):29-31
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_20_20
      Issue No: Vol. 8, No. 1 (2022)
       
  • Pentoxifylline in the treatment of generalized granuloma annulare: A
           report of three cases

    • Authors: Vidya D Kharkar, Harish Balaji Rajendran, Anmol Bhargava
      Pages: 32 - 37
      Abstract: Vidya D Kharkar, Harish Balaji Rajendran, Anmol Bhargava
      Indian Journal of Drugs in Dermatology 2022 8(1):32-37
      Granuloma annulare (GA) is a benign self-limited granulomatous cutaneous disorder of unknown etiology. Clinical variants include localized, generalized, perforating, and subcutaneous. Generalized or disseminated GA is an uncommon variant displaying some clinical features that differentiate it from the localized form, including later age of onset, inadequate response to treatment, and less tendency to spontaneous resolution. The treatment modalities used for localized GA (topical or intralesional steroids, freezing with liquid nitrogen, or surgical excision) cannot be successfully applied to the large numbers of lesions seen in GA’s generalized form. Systemic treatments have included dapsone, chlorambucil, isotretinoin, systemic steroids, cyclosporine, salicylates, chloroquine, and PUVA. These treatments have potentially serious side effects in the long term and have not demonstrated consistent results. Literature overuse of pentoxifylline in the treatment of GA is limited. Here we report three prospective cases of generalized GA showing resolution with oral pentoxifylline.
      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):32-37
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_15_21
      Issue No: Vol. 8, No. 1 (2022)
       
  • Angiolymphoid hyperplasia: Excellent response to polidocanol sclerotherapy

    • Authors: Vikrant M Jadhav, Anil S Gugle, Nitin G Barde
      Pages: 38 - 39
      Abstract: Vikrant M Jadhav, Anil S Gugle, Nitin G Barde
      Indian Journal of Drugs in Dermatology 2022 8(1):38-39

      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):38-39
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_51_19
      Issue No: Vol. 8, No. 1 (2022)
       
  • Gratifying results of apremilast in unstable erythrodermic psoriasis

    • Authors: Meghana Chandrashekhar Rane, Vidya Kharkar
      Pages: 40 - 42
      Abstract: Meghana Chandrashekhar Rane, Vidya Kharkar
      Indian Journal of Drugs in Dermatology 2022 8(1):40-42

      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):40-42
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_27_21
      Issue No: Vol. 8, No. 1 (2022)
       
  • Tetracyclines and niacinamide to the rescue in a case of dermatitis
           herpetiformis

    • Authors: Surender Singh, Siddhi Chikhalkar, Vidya Kharkar, Prateek Oswal
      Pages: 43 - 45
      Abstract: Surender Singh, Siddhi Chikhalkar, Vidya Kharkar, Prateek Oswal
      Indian Journal of Drugs in Dermatology 2022 8(1):43-45

      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):43-45
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_32_21
      Issue No: Vol. 8, No. 1 (2022)
       
  • Acute generalized exanthematous pustulosis: A case highlighting the
           uncommon side effect of a common anti-Covid drug doxycycline in the era of
           Covid-19 pandemic

    • Authors: Ipsita Debata, Debasmita Behera, Chinmoy Raj, Abhishek C Lachure
      Pages: 46 - 48
      Abstract: Ipsita Debata, Debasmita Behera, Chinmoy Raj, Abhishek C Lachure
      Indian Journal of Drugs in Dermatology 2022 8(1):46-48

      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):46-48
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_16_21
      Issue No: Vol. 8, No. 1 (2022)
       
  • Topical steroid induced central serous chorioretinopathy- a rare
           side-effect

    • Authors: Paras Choudhary, Prachi Vinayak Gole, Bhushan Amol Darkase, Balasaheb Vishwas Malkar
      Pages: 49 - 51
      Abstract: Paras Choudhary, Prachi Vinayak Gole, Bhushan Amol Darkase, Balasaheb Vishwas Malkar
      Indian Journal of Drugs in Dermatology 2022 8(1):49-51

      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):49-51
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_40_20
      Issue No: Vol. 8, No. 1 (2022)
       
  • Correlation between percentage of atypical lymphocytes in peripheral smear
           and disease severity based on internal organ involvement in drug reaction
           with eosinophilia and systemic symptoms

    • Authors: Reshma J Neerackal, Dhanya Mohan, Anand G Archana, Biju George, Aparna Govindan, Chettithodi Sivasankaran Bindu, Sarita Sasidharanpillai
      Pages: 52 - 54
      Abstract: Reshma J Neerackal, Dhanya Mohan, Anand G Archana, Biju George, Aparna Govindan, Chettithodi Sivasankaran Bindu, Sarita Sasidharanpillai
      Indian Journal of Drugs in Dermatology 2022 8(1):52-54

      Citation: Indian Journal of Drugs in Dermatology 2022 8(1):52-54
      PubDate: Sat,11 Jun 2022
      DOI: 10.4103/ijdd.ijdd_12_21
      Issue No: Vol. 8, No. 1 (2022)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.238.125.76
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-